Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

NCT00703820 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

324

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Etoposide
DRUG: Clofarabine
DEVICE: CliniMACS

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]